Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001203311-12-000054)

Filing Details

Accession Number:: 0001203311-12-000054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-06-08 19:45:39
Reporting Period:: 2012-06-08

Filing Date:: 2012-06-08
Accepted Time:: 2012-06-08 19:45:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seattle Genetics Inc	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216477	E Todd Simpson	21823 30Th Drive Se Bothell WA 98021	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-08	35,000	$5.20	85,762	No	4	M	Direct
Common Stock	Disposition	2012-06-08	35,000	$22.97	50,762	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-06-08	35,000	$0.00	35,000	$5.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
75,417		2015-10-04	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Simpson on June 20, 2011.
Amount of securities beneficially owned following reported transactions includes 21,220 Restricted Stock Units subject to vesting.
Shares shall vest at a rate of 25% on October 4, 2006 and monthly thereafter until all shares are fully vested on October 4, 2009.